Results 161 to 170 of about 5,072,317 (340)

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias   +12 more
wiley   +1 more source

Evaluation Method for Quality Risks of Safety in Prefabricated Building Construction Using SEM-SDM Approach. [PDF]

open access: yesInt J Environ Res Public Health, 2022
Li X   +4 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Insect-proofing during building construction

open access: yesCalifornia Agriculture, 1969
Insect proofing at the time of construction offers new challenge and opportunity to the building and pest control industries. It provides the opportunity for prevention, which is generally less expensive and always more satisfactory than cure.
W Ebeling, R Wagner, D Reierson
doaj  

Quantifying and managing plastic waste generated from building construction in Auckland, New Zealand. [PDF]

open access: yesWaste Manag Res, 2023
Hernandez G   +6 more
europepmc   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

A construction classification system database for understanding resource use in building construction. [PDF]

open access: yesSci Data, 2022
Guven G   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy